Semaglutide: A Revolution in Obesity Treatment (Case of France)
From Diabetes Treatment to Weight Loss Semaglutide, known as Ozempic for treating type 2 diabetes, gained significant attention due to its unexpected side effect: significant weight loss. Today, it is marketed under the name Wegovy for obesity treatment, with a higher dosage. In France, it has been available since October 8, although reimbursement is still…